In previous studies on the energy metabolism phenotypes of PAH, PASMCs showed enhanced glycolysis, activation of the hypoxia-inducible factor HIF1 even under normoxia, and upregulation of oncogenes in human and animal models of PAH [13,14,15]. The gene discussed is HIF1A; the disease is pulmonary arterial hypertension.